Philip Liebson to Humans
This is a "connection" page, showing publications Philip Liebson has written about Humans.
Connection Strength
0.549
-
Stem-cell angiogenesis and regeneration of the heart: review of a saga of 2 decades. Clin Cardiol. 2015 May; 38(5):309-16.
Score: 0.027
-
Cardiovascular disease in special populations III: stroke. Prev Cardiol. 2010; 13(1):1-7.
Score: 0.018
-
Cardiovascular risk in special populations IV: Congenital heart defects. Prev Cardiol. 2010; 13(2):49-55.
Score: 0.018
-
Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
Score: 0.017
-
Cardiovascular risk in special populations: overview. Prev Cardiol. 2009; 12(3):121-7.
Score: 0.017
-
Cardiovascular risk in special populations II: hypertension. Prev Cardiol. 2009; 12(4):189-97.
Score: 0.017
-
ENHANCE and ONTARGET. Prev Cardiol. 2008; 11(3):179-82.
Score: 0.016
-
Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother. 2006 Dec; 7(17):2385-401.
Score: 0.015
-
Muraglitazar and the FDA: what constitutes drug safety? Prev Cardiol. 2006; 9(2):110-4.
Score: 0.014
-
VALIANT and EUROPA. Prev Cardiol. 2004; 7(1):42-4.
Score: 0.012
-
VISP and INVEST. Prev Cardiol. 2004; 7(2):93-6.
Score: 0.012
-
ALLHAT and AFFIRM. Prev Cardiol. 2003; 6(1):54-60.
Score: 0.011
-
LIFE and ARBITER. Prev Cardiol. 2003; 6(2):108-11.
Score: 0.011
-
AVID and COMET. Prev Cardiol. 2003; 6(4):218-20.
Score: 0.011
-
ASAP and ANTIBIO. Prev Cardiol. 2003; 6(3):166-8.
Score: 0.011
-
Transesophageal echocardiography in critically ill patients: what is the intensivist's role? Crit Care Med. 2002 May; 30(5):1165-6.
Score: 0.011
-
Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001 Aug 14; 104(7):779-82.
Score: 0.010
-
Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy. Curr Hypertens Rep. 2000 Jun; 2(3):260-70.
Score: 0.009
-
Prevention of coronary heart disease. Part II. Secondary prevention, detection of subclinical disease, and emerging risk factors. Dis Mon. 2000 Jan; 46(1):1-123.
Score: 0.009
-
Prevention of coronary heart disease. Part I. Primary prevention. Dis Mon. 1999 Dec; 45(12):497-571.
Score: 0.009
-
Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med. 1997 Mar 24; 157(6):638-48.
Score: 0.008
-
The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis. 1997 Mar-Apr; 39(5):399-444.
Score: 0.008
-
Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging. 1996 Oct; 10(4):261-5.
Score: 0.007
-
Regression of left ventricular hypertrophy. JAMA. 1996 Aug 21; 276(7):526-7.
Score: 0.007
-
Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide. Am J Hypertens. 1996 May; 9(5):445-54.
Score: 0.007
-
Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort. JAMA Cardiol. 2016 04 01; 1(1):15-25.
Score: 0.007
-
Is the echocardiogram an appropriate ECG validity standard for the detection and change in left ventricular size? J Electrocardiol. 1996; 29 Suppl:248-55.
Score: 0.007
-
Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension (results from Treatment of Mild Hypertension Study). Am J Cardiol. 1995 Jun 15; 75(17):1233-8.
Score: 0.007
-
Relations between subclinical disease markers and type 2 diabetes, metabolic syndrome, and incident cardiovascular disease: the Jackson Heart Study. Diabetes Care. 2015 Jun; 38(6):1082-8.
Score: 0.007
-
Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans. J Am Heart Assoc. 2015 Feb 05; 4(2).
Score: 0.007
-
Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1995 Feb 01; 91(3):698-706.
Score: 0.007
-
Semiautomatic evaluation of left ventricular diastolic function with cine magnetic resonance imaging. Acad Radiol. 1994 Nov; 1(3):237-42.
Score: 0.006
-
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23; 130(25):e344-426.
Score: 0.006
-
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23; 130(25):2354-94.
Score: 0.006
-
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23; 64(24):e139-e228.
Score: 0.006
-
Coronary angiography in patients with established coronary artery disease: how much does the angiogram help in assessing changes in symptoms? Cathet Cardiovasc Diagn. 1994 Aug; 32(4):330-1.
Score: 0.006
-
Dobutamine stress echocardiography: what role in today's ICU? J Crit Illn. 1994 Jul; 9(7):702-8.
Score: 0.006
-
The technique of dobutamine stress echocardiography. J Crit Illn. 1994 Jul; 9(7):711-9.
Score: 0.006
-
Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1993 Feb; 87(2):476-86.
Score: 0.006
-
Intravascular ultrasound in coronary atherosclerosis: a new approach to clinical assessment. Am Heart J. 1992 Jun; 123(6):1643-60.
Score: 0.005
-
Getting best results from echocardiography in emergency situations. Indications include shock, infarction, heart failure, trauma, tamponade. J Crit Illn. 1992 May; 7(5):698-710.
Score: 0.005
-
How best to use echocardiography for definitive assessment. Methods of estimating valvular integrity, LV function, pulmonary pressure. J Crit Illn. 1992 May; 7(5):715-28.
Score: 0.005
-
What role for echocardiography in primary pulmonary hypertension? New ultrasound methods accurately estimate pulmonary pressures. J Crit Illn. 1991 Sep; 6(9):882-8.
Score: 0.005
-
The relation of diabetes, impaired fasting blood glucose, and insulin resistance to left ventricular structure and function in African Americans: the Jackson Heart Study. Diabetes Care. 2011 Feb; 34(2):507-9.
Score: 0.005
-
Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens. 1990 Jun; 3(6 Pt 1):512-7.
Score: 0.005
-
Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: the Jackson Heart Study (JHS). Am Heart J. 2009 Aug; 158(2):209-16.
Score: 0.004
-
Comparison of auscultation with two-dimensional and Doppler echocardiography in patients with suspected mitral valve prolapse. Clin Cardiol. 1988 Jun; 11(6):401-6.
Score: 0.004
-
Hypertension research. Echocardiography in the measurement of left ventricular wall mass. Hypertension. 1987 Feb; 9(2 Pt 2):II2-5.
Score: 0.004
-
Echocardiographic studies of regression of left ventricular hypertrophy in hypertension. Hypertension. 1987 Feb; 9(2 Pt 2):II65-8.
Score: 0.004
-
Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study. Cardiovasc Ultrasound. 2006 Nov 08; 4:43.
Score: 0.004
-
Hypertensive crisis. Med Clin North Am. 1986 Jul; 70(4):749-67.
Score: 0.004
-
Mitral valve prolapse: recent advances in diagnosis and therapy. Compr Ther. 1986 Jun; 12(6):21-32.
Score: 0.004
-
Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the Atherosclerotic Risk in Communities study. Stroke. 2005 Mar; 36(3):546-50.
Score: 0.003
-
Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women. Am J Cardiol. 2004 Dec 01; 94(11):1383-90.
Score: 0.003
-
Echocardiographic diagnosis of mobile right atrial thrombus: early recognition and treatment. Am Heart J. 1984 Dec; 108(6):1548-50.
Score: 0.003
-
Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension. 2005 Jan; 45(1):58-63.
Score: 0.003
-
Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective. Cardiol Rev. 2004 Nov-Dec; 12(6):287-98.
Score: 0.003
-
Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004 Jun 03; 93(11A):32C-48C.
Score: 0.003
-
Determining the specific etiology of a new mitral bioprosthetic murmur using echo-phonocardiography. J Clin Ultrasound. 1984 Feb; 12(2):105-7.
Score: 0.003
-
Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Vasc Med. 2004 Feb; 9(1):7-12.
Score: 0.003
-
Left ventricular structure and systolic function in African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Ethn Dis. 2004; 14(4):483-8.
Score: 0.003
-
Comparison of m-mode echocardiographic left ventricular mass measured using digital and strip chart readings: the Atherosclerosis Risk in Communities (ARIC) study. Cardiovasc Ultrasound. 2003 Jun 27; 1:8.
Score: 0.003
-
Risk stratification post-myocardial infarction: is early coronary angiography the more effective strategy? Prog Cardiovasc Dis. 2002 Jul-Aug; 45(1):49-66.
Score: 0.003
-
One-year study of felodipine or placebo for stage 1 isolated systolic hypertension. Hypertension. 2001 Nov; 38(5):1118-23.
Score: 0.003
-
Mitral valve prolapse. Compr Ther. 1981 Oct; 7(10):34-41.
Score: 0.003
-
Counterpulsation and dobutamine. Their use in treatment of cardiogenic shock due to right ventricular infarct. Arch Intern Med. 1981 Feb; 141(2):247-9.
Score: 0.002
-
Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study. J Hypertens. 2001 Jan; 19(1):127-34.
Score: 0.002
-
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. Hypertension. 2000 Jan; 35(1 Pt 1):6-12.
Score: 0.002
-
Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? J Am Coll Cardiol. 1999 Jan; 33(1):107-18.
Score: 0.002
-
Comparison of cine magnetic resonance imaging and Doppler echocardiography for evaluation of left ventricular diastolic function. Am J Cardiol. 1997 Aug 01; 80(3):384-6.
Score: 0.002
-
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension. 1997 Jan; 29(1 Pt 1):8-14.
Score: 0.002
-
Chronobiology of acute myocardial infarction: cardiac arrhythmia suppression trial (CAST) experience. Am J Cardiol. 1996 Dec 01; 78(11):1198-201.
Score: 0.002
-
Relation of circadian ventricular ectopic activity to cardiac mortality. CAST Investigators. Am J Cardiol. 1996 Oct 15; 78(8):881-5.
Score: 0.002
-
Smoking cessation and arrhythmic death: the CAST experience. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. J Am Coll Cardiol. 1995 Nov 01; 26(5):1287-92.
Score: 0.002
-
Circadian variations in cardiac disease: clinical implications. Current strategies for preventing MI, dysrhythmias, sudden death. J Crit Illn. 1995 Oct; 10(10):693-6, 699-700, 705-7.
Score: 0.002
-
Cardiac performance during pregnancy: serial evaluation using external systolic time intervals. Am J Obstet Gynecol. 1975 May 01; 122(1):1-8.
Score: 0.002
-
Urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in mild hypertension. Am J Hypertens. 1994 Nov; 7(11):965-74.
Score: 0.002
-
Echocardiography in multicenter clinical trials: experience from the Treatment of Mild Hypertension Study. Control Clin Trials. 1994 Oct; 15(5):395-410.
Score: 0.002
-
Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST). J Am Coll Cardiol. 1994 Feb; 23(2):283-9.
Score: 0.002
-
Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA. 1993 Nov 24; 270(20):2451-5.
Score: 0.002
-
Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Suppression Trial (CAST) experience. J Am Coll Cardiol. 1993 Oct; 22(4):998-1003.
Score: 0.001
-
Electrocardiographic abnormalities in mitral valve prolapse. Am J Cardiol. 1992 Jul 15; 70(2):265-6.
Score: 0.001
-
Validation of computerized three-dimensional reconstruction of intravascular ultrasound: measurements of absolute luminal diameter and cross-sectional area in ex vivo human coronary arteries. J Invasive Cardiol. 1992 May; 4(4):179-87.
Score: 0.001
-
Population-derived comparisons of ambulatory and office blood pressures. Implications for the determination of usual blood pressure and the concept of white coat hypertension. Arch Intern Med. 1992 Apr; 152(4):750-6.
Score: 0.001
-
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21; 324(12):781-8.
Score: 0.001
-
Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients. Am J Cardiol. 1989 Jun 05; 63(19):69I-74I.
Score: 0.001
-
Determination of cardiac output in critically ill patients by dual beam Doppler echocardiography. J Am Coll Cardiol. 1989 Feb; 13(2):340-7.
Score: 0.001
-
Comparison of auscultation with two-dimensional and Doppler echocardiography in patients with suspected mitral valve prolapse. Clin Cardiol. 1988 Oct; 11(10):A30.
Score: 0.001
-
Visualization of an anomalous left main coronary artery with two-dimensional echocardiography. Am Heart J. 1988 Feb; 115(2):468-70.
Score: 0.001
-
Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension. 1987 Feb; 9(2 Pt 2):II69-76.
Score: 0.001
-
Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension. 1987 Feb; 9(2 Pt 2):II97-104.
Score: 0.001
-
Palpitations in a patient with morbid obesity. Right atrial thrombus. Arch Intern Med. 1985 Mar; 145(3):519-20.
Score: 0.001
-
The conduction system in mitral valve prolapse syndrome with sudden death. Am Heart J. 1981 May; 101(5):667-70.
Score: 0.001
-
Use of noninvasive methods in evaluation of left ventricular performance in coronary artery disease. II: Change in systolic time intervals after coronary artery bypass in patients with stable angina. Br Heart J. 1976 Nov; 38(11):1166-72.
Score: 0.000
-
Assessment of left ventricular function in secundum atrial septal defect: evaluation by determination of volume, pressure, and external systolic time indices. Pediatr Res. 1975 Dec; 9(12):894-9.
Score: 0.000
-
Acute myocardial infarction diagnosed by myoglobinuria. Arch Intern Med. 1975 Sep; 135(9):1181-3.
Score: 0.000
-
The use of noninvasive methods in the evaluation of left ventricular performance in coronary artery disease. I. Relation of systolic time intervals to angiographic assessment of coronary artery disease severity. Am Heart J. 1975 Aug; 90(2):134-44.
Score: 0.000